Gregor Jemec
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa (NCT04982432) | Gregor Jemec | 2021-10-01 |
Track Gregor Jemec automatically
Every clearance here is in the API, with alerts when new ones post.